ThyroKare

For use in horses for correction of conditions associated with low circulating thyroid hormone (hypothyroidism).

The suggested initial dose is 0.5 to 3.0 mg levothyroxine sodium (T-4) per 100 lbs of body weight (1 to 6 mg per 100 kg) once per day or in divided doses. Response to the administration of ThyroKare Powder should be evaluated clinically until an adequate maintenance dose is established. In most horses, the total daily dose of T-4 is in the range of 6 to 36 mg. Serum T-3 and T-4 values can vary greatly among inidividual horses on thyroid supplementation. Dosages should be individualized and animals should be monitored daily for clinical signs of hyperthyroidism or hypersensitivity.

Administration:

ThyroKare Powder can be administered by mixing the daily dose in the concentrate or by top dressing on the grain, preferably rolled or ground. To facilitate the proper adhesion of ThyroKare Powder to the ration, slightly moisten the grain with water or a liquid supplement.

Store at 20°-25°C (68°-77°F) with excursions between 15°-30°C (59°-86°F) and protect from light.

Administer with caution to animals with clinically significant heart disease, hypertension, or other complications for which a sharply increased metabolic rate might prove hazardous. Use in pregnant mares has not been evaluated.

Lot No.:

Exp. Date:

Manufactured by:

Neogen Corporation

Lexington, KY 40511

859-254-1221 or 800-621-8829

animalsafety.neogen.com

Made in USA

NDC: 59051-9128-9

ThyroKare™ Equine Powder

Levothyroxine Sodium USP

(0.22%)

CAUTION: Federal law restricts this drug to use by or on the order of a licensed veterinarian.

NEOGENVet

Net Contents: 10 lb (4.536 kg)

L3396-0816

Thyrokare 10lb